Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy.
Hu Y, Ye Z, Wang F, Qin Y, Xu X, Yu X, Ji S.
Front Endocrinol (Lausanne). 2021 May 19;12:679000. doi: 10.3389/fendo.2021.679000. eCollection 2021.
Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management.
Ma ZY, Gong YF, Zhuang HK, Zhou ZX, Huang SZ, Zou YP, Huang BW, Sun ZH, Zhang CZ, Tang YQ, Hou BH.
World J Gastroenterol. 2020 May 21;26(19):2305-2322. doi: 10.3748/wjg.v26.i19.2305.
Surgical techniques and postoperative management to prevent postoperative pancreatic fistula after pancreatic surgery.
Kawaida H, Kono H, Hosomura N, Amemiya H, Itakura J, Fujii H, Ichikawa D.
World J Gastroenterol. 2019 Jul 28;25(28):3722-3737. doi: 10.3748/wjg.v25.i28.3722.
Somatostatin analogues for pancreatic surgery.
Gurusamy KS, Koti R, Fusai G, Davidson BR.
Cochrane Database Syst Rev. 2010 Feb 17;(2):CD008370. doi: 10.1002/14651858.CD008370.
Somatostatin.
Efendić S, Hökfelt T, Luft R.
Adv Metab Disord. 1978;9:367-424. doi: 10.1016/b978-0-12-027309-6.50023-9.
Somatostatinoma.
Unger RH.
N Engl J Med. 1977 Apr 28;296(17):998-1000. doi: 10.1056/NEJM197704282961713.
Metastatic pancreatic neuroendocrine tumors have decreased somatostatin expression and increased Akt signaling.
Tran CG, Scott AT, Li G, Sherman SK, Ear PH, Howe JR.
Surgery. 2021 Jan;169(1):155-161. doi: 10.1016/j.surg.2020.04.034. Epub 2020 Jun 29.
Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours.
de Herder WW, Hofland LJ, van der Lely AJ, Lamberts SW.
Endocr Relat Cancer. 2003 Dec;10(4):451-8. doi: 10.1677/erc.0.0100451.
[Somatostatinomas].
Pinsard D, Chadenas D.
Diabete Metab. 1988 Jan-Feb;14(1):43-59.
The clinical significance of somatostatin in pancreatic diseases.
Sliwińska-Mossoń M, Veselý M, Milnerowicz H.
Ann Endocrinol (Paris). 2014 Sep;75(4):232-40. doi: 10.1016/j.ando.2014.06.004. Epub 2014 Aug 22.
